Soluble CD30 serum antigen in Kawasaki disease

4Very high levels of sCD30, a glycoprotein surface antigen expressed by T lymphocytes and other mononuclear cells of the immune system, were found in serum samples from 10 children with typical Kawasaki disease (KD), but not in blood specimens from a vast cohort of paediatric control subjects. These data strongly support an involvement of CD30+T cells in the immune processes which take place at the level of lymphoid organs during the acute phase of KD.

[1]  A. Bertotto,et al.  Tuberculin Skin Test Reactivity in Kawasaki Disease , 1997, Pediatric Research.

[2]  A. Bertotto,et al.  Mantoux test in Kawasaki disease. , 1996, Pediatrics.

[3]  R. V. van Lier,et al.  CD30 expression does not discriminate between human Th1- and Th2-type T cells. , 1996, Journal of immunology.

[4]  B. Falini,et al.  High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints , 1995, Clinical and experimental immunology.

[5]  J. Lamb,et al.  Evidence for a superantigen mediated process in Kawasaki disease. , 1995, Archives of disease in childhood.

[6]  R. Fisher,et al.  IL-12 activates IFN-gamma production through the preferential activation of CD30+ T cells. , 1995, Journal of immunology.

[7]  M. de Carli,et al.  Preferential expression of CD30 by human CD4+ T cells producing Th2‐type cytokines , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  G. Pizzolo,et al.  CD30, Th2 cytokines and HIV infection: a complex and fascinating link. , 1995, Immunology today.

[9]  S. Dower,et al.  The TNF ligand superfamily and its relevance for human diseases. , 1995, Cytokines and molecular therapy.

[10]  F. Stirpe,et al.  CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. , 1995, Blood.

[11]  G. Pizzolo,et al.  CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection , 1994, The Journal of experimental medicine.

[12]  K. Yabuta,et al.  Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. , 1994, The Journal of pediatrics.

[13]  T. Fujisawa,et al.  Increased Expression of Human 63-kD Heat Shock Protein Gene in Kawasaki Disease Determined by Quantitative Reverse Transcription-Polymerase Chain Reaction , 1994, Pediatric Research.

[14]  A. Yachi,et al.  Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. , 1992, Arthritis and rheumatism.

[15]  K. Yabuta,et al.  Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. , 1992, Archives of Disease in Childhood.

[16]  T. Kohsaka,et al.  Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Abe.  Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease , 1992 .

[18]  F. Orson,et al.  Abnormalities of immunoregulation in Kawasaki syndrome. , 1988, The Journal of rheumatology.